(Q33584259)

28 July 2017

title

Design of the anti-tuberculosis drugs induced adverse reactions in China National Tuberculosis Prevention and Control Scheme Study (ADACS). (English)

1 reference

People's Republic of China

28 July 2017

0 references

0 references

author name string

Yin Yin Xia

1

1 reference

28 July 2017

Dai Yu Hu

2

1 reference

28 July 2017

Fei Ying Liu

3

1 reference

28 July 2017

Xiao Meng Wang

4

1 reference

28 July 2017

Yan Li Yuan

5

1 reference

28 July 2017

De Hua Tu

6

1 reference

28 July 2017

Yi Xin Chen

7

1 reference

28 July 2017

Lin Zhou

8

1 reference

28 July 2017

Li Zhen Zhu

9

1 reference

28 July 2017

Wei Wei Gao

10

1 reference

28 July 2017

Hong Yuan Wang

11

1 reference

28 July 2017

Da Fang Chen

12

1 reference

28 July 2017

Li Yang

13

1 reference

28 July 2017

Ping Ping He

14

1 reference

28 July 2017

Xiao Ting Li

15

1 reference

28 July 2017

Ying Jian He

16

1 reference

28 July 2017

Feng Sun

17

1 reference

28 July 2017

Si Yan Zhan

18

1 reference

28 July 2017

language of work or name

English

0 references

publication date

21 May 2010

1 reference

28 July 2017

1 reference

28 July 2017

volume

10

1 reference

28 July 2017

page(s)

267

1 reference

Drugs and herbs given to prevent hepatotoxicity of tuberculosis therapy: systematic review of ingredients and evaluation studies

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893093

Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893093

Incidence of hepatotoxicity due to antitubercular medicines and assessment of risk factors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893093

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893093

Hepatotoxicity of tuberculosis chemotherapy under general programme conditions in Singapore

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893093

The DOTS strategy in China: results and lessons after 10 years

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893093

Drug-induced liver disorders: implications for drug development and regulation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893093

Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893093

Liver injury during antituberculosis treatment: an 11-year study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893093

Frequency and type of reactions to antituberculosis drugs: observations in routine treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893093

Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893093

Hepatotoxicity from isoniazid and rifampin in inner-city AIDS patients.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893093

Isoniazid-rifampin-induced hepatitis in hepatitis B carriers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893093

USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893093

Anti-tuberculosis medication side-effects constitute major factor for poor adherence to tuberculosis treatment

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-267

Somatic complaints and isoniazid (INH) side effects in Latino adolescents with latent tuberculosis infection (LTBI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-267

Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-267

Drug-induced liver injury: mechanisms and test systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-267

Raltitrexed-induced hepatotoxicity: multivariate analysis of predictive factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-267

A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-267

A prospective clinical study of isoniazid-rifampicin-pyrazinamide-induced liver injury in an area endemic for hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-267

Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-267

Pattern of adverse drug reactions experienced by tuberculosis patients in a tertiary care teaching hospital in Western Nepal.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893093

Automated forensic DNA purification optimized for FTA card punches and identifiler STR-based PCR analysis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893093

The influence of risk factors on the severity of anti-tuberculosis drug-induced hepatotoxicity.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893093

Side effects of chemotherapy in patients with pulmonary tuberculosis and concomitant diseases

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893093

Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection

31 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-267

Six-months isoniazid-rifampin therapy for pulmonary tuberculosis. Report of a United States Public Health Service Cooperative Trial

21 January 2018

1 reference

12 December 2020

Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis

1 reference

12 December 2020

Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic

1 reference

12 December 2020

[Systematic review of anti-tuberculosis drug induced adverse reactions in China]

1 reference

12 December 2020

Adverse effects of tuberculosis treatment: experience at an outpatient clinic of a teaching hospital in the city of São Paulo, Brazil

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2458-10-267

1 reference

Dimensions Publication ID

28 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2458-10-267

9 September 2019

1 reference

28 July 2017

1 reference